Day: October 13, 2022

Oct 13
Albertsons stock heads higher amid report of Kroger merger interest

Shares of Albertsons Cos. Inc. ACI, +12.13% were up more than 11% in Thursday morning trading after Bloomberg News reported that Kroger Co. KR, was in merger talks with the smaller grocer. Kroger shares were down more than 2%. The report cited anonymous sources and noted that while a deal could be hammered out as […]

Oct 13
Bank of China: Digital yuan transactions volume crossed $14B mark

The largest CBDC pilot in the world is going to expand on citizen payments and cross-border operations with Hong Kong. 2849 Total views 47 Total shares China’s central bank digital currency (CBDC) project has reached the mark of close to $14 billion, or 100.04 billion yuan, of made transactions during its pilot phase. It makes […]

Oct 13
USA Today parent Gannett mandates 5 days of unpaid leave in December, seeking voluntary layoffs in latest cost cuts

Gannett Co. Inc. GCI, -3.93% informed staff on Wednesday that it’s temporarily suspending its 401(k) match from Oct. 24 and mandating five days of unpaid leave in December, as part of a latest round of cost cuts. In a memo circulated by Editor & Publisher, Chief Executive Mike Reed said the publisher is also offering […]

Oct 13
Murrey Math Lines 13.10.2022 (USDCHF, XAUUSD)

USDCHF, “US Dollar vs Swiss Franc” As we can see in the H4 chart, USDCHF is trading above the 200-day Moving Average to indicate a possible ascending tendency. The Relative Strength Index has rebounded from the ascending trendline. In this case, the pair is expected to break 6/8 (1.0009) and then continue growing towards the […]

Oct 13
Japanese Candlesticks Analysis 13.10.2022 (USDCAD, AUDUSD, USDCHF)

USDCAD, “US Dollar vs Canadian Dollar” As we can see in the H4 chart, after forming a Hanging Man reversal pattern close to the resistance level, USDCAD may reverse in the form of a new descending wave. In this case, the downside correctional target may be at 1.3745. Later, the market may rebound from the […]

Oct 13
Barclays now sees 5%-5.25% fed funds rate by February on the back of ‘more aggressive, front-loaded’ Fed hikes

Barclays lifted its expectations for the next few rate hikes by the Federal Reserve on Thursday following September’s hotter-than-expected consumer-price-index report. The firm now expects 75 basis point rate hikes each at the Fed’s November and December meetings, versus a prior expectation for a 50-basis-point move in the final month of the year, according to […]

Oct 13
Chance of fed-funds rate target at or above 5% by March jumps to almost 43% after September CPI

Traders see a 42.6% likelihood that the fed-funds rate target will get to between 5% and 5.25%, or even higher, by next March after Thursday’s hotter-than-expected consumer-price index report for September. That’s up from 6.1% on Wednesday, according to the CME FedWatch Tool. The CPI report also cemented a 95.8% chance of a 75-basis-point rate […]

Oct 13
U.S. stocks open sharply lower, Dow drops more than 500 points after hotter-than-expected inflation report

U.S. stocks opened sharply lower Thursday, with the Dow Jones Industrial Average falling more than 500 points, after the consumer-price index showed that inflation in September was hotter than forecast. The Dow DJIA, +2.31% was down 1.7% soon after the opening bell, while the S&P 500 SPX, +2.22% fell about 2.2% and the Nasdaq Composite […]

Oct 13
Patterson Cos. names new CEO, after Mark Walchirk resigns after violating policy, demonstrating poor judgment

Patterson Companies Inc. PDCO, +2.68% said Thursday that is has named Don Zurbay as chief executive officer. Zurbay, who was most recently the dental and animal health company’s chief financial officer, succeeds Mark Walchirk as CEO. Walchirk had resigned from the company, after it was determined that he “violated company policy and demonstrated poor judgment […]

Oct 13
Relmada’s stock tumbles 80% after its depressive disorder drug failed a late-stage study

Shares of Relmada Therapeutics Inc. RLMD, -78.23% fell 80.0% in premarket trading on Thursday after the biotech said its experimental treatment for major depressive disorder as a monotherapy did not meet the primary endpoint in a Phase 3 clinical trial. The company said it is still enrolling patients in two other late-stage studies assessing the […]